Holt, MI - Orchid Orthopedic Solutions
(Orchid), a worldwide leader in design and manufacturing for the
orthopedic and medical device industry, is pleased to announce it has
signed an agreement to acquire the Cam Bioceramics coating facility and
operations in Suzhou (Cam China), a high quality provider of
hydroxylapatite (HA) plasma coatings in China. The transaction is
expected to close in December of 2015.
Holt, MI - Orchid Orthopedic Solutions
(Orchid), a worldwide leader in design and manufacturing for the
orthopedic and medical device industry, is pleased to announce it has
signed an agreement to acquire the Cam Bioceramics coating facility and
operations in Suzhou (Cam China), a high quality provider of
hydroxylapatite (HA) plasma coatings in China. The transaction is
expected to close in December of 2015.
The
acquisition of the high quality coating facility in China further
strengthens Orchid’s role as a global coating leader. Orchid can now
offer world-class coating capabilities in the U.S., Europe and Asia to
its customers. The acquisition also creates a base for Orchid to further
expand its capabilities in China to serve the growing demands in the
market.
“The
acquisition of Cam China strongly commits Orchid to the market in Asia.
We will continue to expand our manufacturing platform and coating
capabilities in China to support the growing demand from our global and
local customers,” said Christopher Norbye, Orchid’s International Executive Vice President, based in China.
”We
are convinced that Orchid is the perfect company to continue the
development of the operations and relationships we have built over the
last four years in China and I am confident the team in China will have
great opportunities to grow the business together with Orchid going
forward,” said Gerard Kok, the founder and owner of Cam Bioceramics.
Cam Bioceramics is a global orthobiologic materials innovator specializing
in calcium phosphates. By divesting its China coating facility to
Orchid, Cam Bioceramics is focusing on its core business: the
engineering, development and contract manufacturing of orthobiologic
calcium compositions. The company is based in Leiden, the Netherlands
and its Dutch ownership remains unchanged.
About Orchid Coatings
Orchid’s
coating technology and experience extends 20+ years in the US and
Europe, and is extended further with the new offerings in Asia. Orchid’s
coatings and surface treatments now include spherical bead,
Asymmatrix®, Osseomatrix®, titanium plasma spray, hydroxylapatite (HA),
VPS on PEEK, VPS Ti on Polyethylene, ceramic coatings and Resorbable
Blast Media (RBM).
About Orchid
Orchid
is a worldwide leader in design and manufacturing for the orthopedic
and medical device markets. Orchid is able to do this by compressing
time to market, providing new technologies and being the best total
supply-chain value. Besides coating technologies Orchid provides
expertise in design and development, quality and regulatory support,
implant manufacture, advanced machining, plastics technology, instrument
manufacturing, and packaging services. With 14 world-class facilities
located around the globe, Orchid continues to provide others an
opportunity to live a better life through the products, services and the
way the company does business. For more information about Orchid, visit
the company’s website at www.orchid-ortho.com.